LIST OF APIs


API Manufacturing Unit Grade CAS No. Documentation Regulatory Approvals
Anti-Histamine / Anti-Cholinergic
Buclizine HCl Unit – I BP, IP 129-74-8 CTD DMF COFEPRIS, WHO GMP, WC, IRELAND
Cinnarizine Unit – I EP, BP, IP 298-57-7 CTD DMF, EDMF, CEP COFEPRIS, WHO GMP, WC, IDL(China), MOH(Russia),EUGMP
Cyclizine HCl Unit – I EP, BP, USP 82-92-8 CTD DMF WHO GMP
Cyproheptadine HCl Unit – I EP, BP, USP 41354-29-4 CTD DMF COFEPRIS, WHO GMP, IDL(China)
Meclizine HCl Unit – I EP, BP, USP 31884-77-2 CTD DMF, CEP(U/R), JDMF, USDMF PMDA Japan, WHO GMP, WC, COFEPRIS, Netherlands
Oxatomide IH Unit – I IH 60607-34-3 CTD DMF WHO GMP
Hydroxyzine HCl Unit – I USP, EP 2192-20-3 DMF: SEP-18 GMP
Ketotifen Fumarate Unit – II EP, BP 34580-14-8 CTD DMF WHO GMP
Muscle relaxant / Pain Management
Carisoprodol Unit – I EP, USP, IP 78-44-4 CTD DMF, USDMF COFEPRIS, WHO GMP
Etodolac Unit – I EP, BP, USP, IP 41340-25-4 CTD DMF, CEP, USDMF WHO GMP
Pentoxifylline Unit – I EP, USP 06-05-6493 CTD DMF, CEP(U/R) WHO GMP
Cardiovascular
Diltiazem HCl Unit – I EP, BP, USP, IP 33286-22-5 CTD DMF : Aug-18, USDMF, CEP : Nov-18 WHO GMP
Clopidogrel Form II Unit – I EP, USP, IP 120202-66-6 CTD DMF : May-18, USDMF, CEP : Jun-18 GMP
Anti-Migraine
Flunarizine HCl Unit – I EP, BP 30484-77-6 CTD DMF, EDMF,CEP(U/R) COFEPRIS, WHO GMP, WC
Chelating agent
Etidronate Disodium Unit – I EP, USP 7414-83-7 CTD DMF CANADIAN AUTHORITY
Anti-Diarrheal
Loperamide HCl Unit – I EP, BP, USP 34552-83-5 CTD DMF, EDMF, CEP (U/R) WHO GMP, COFEPRIS, MOH(Russia)
Glaucoma, Ocular Hypertension
Latanoprost Unit – I IH 130209-82-4 DMF : Sep-18 GMP
Bimatoprost Unit – I IH 155206-00-1 DMF : Sep-18 GMP
Travoprost Unit – I IH 157283-68-6 DMF : Sep-18 GMP
Ocular Hypertension
Tafluprost Unit – I IH 209860-87-7 DMF : Sep-18 GMP
Oxytocic
Carboprost Unit – I IH 58551-69-2 DMF : Sep-18 GMP
Misoprostol Unit – I IH 59122-46-2 DMF : Sep-18 GMP
Treat Wilson’s Disease
D-Penicillamine Unit – II IP, EP, USP 52-67-5 TechPack GMP
Treat Osteoporosis
Ibandronate Sodium Unit – II IH 138926-19-9 CTD DMF, KDMF KFDA, WHO GMP
Risedronate Sodium (HH/AH) Unit – II EP, BP, USP 115436-72-1 CTD DMF, KDMF KFDA, WHO GMP
Anti-Muscarinic
Tolterodine Tartrate Unit – II IP, USP, IH 124937-52-6 CTD DMF WHO GMP

Note:

  • Products covered under Patent will not be supplied to the countries where Patents are valid
  • Products covered under valid Patent are available for R & D use only
  • U/R – “Under Review”, IH – “In-house”